Empagliflozin

Jardiance

Other GLP-1 Oral FDA/EMA Label

Half-life

12.4 hr

Time to Peak

1.5 hr

Steady State

~3 days

Dose Range

10–25 mg

Frequency

once daily

Overview

SGLT2 inhibitor — causes glucose excretion in urine, reducing blood sugar independently of insulin. Also provides cardiovascular and renal protective benefits. Commonly co-prescribed alongside GLP-1 agonists.

Mechanism of Action

Selective inhibitor of sodium-glucose co-transporter 2 (SGLT2) in the proximal renal tubule. Reduces renal glucose reabsorption, causing glucosuria and lowering blood glucose.

Dosing Information

Route	Dose Range	Half-life	Tmax	Frequency
Oral	10–25 mg	12.4 hr	1.5 hr	once daily

Used in Regimens

Empagliflozin is not currently part of any catalog regimen.

Data Sources

FDA Label Jardiance (empagliflozin) FDA Prescribing Information

Related Tools

Medication Level Plotter

See blood level curves for this compound

Dose Calculator

Calculate reconstitution and draw volumes

Split Dose Calculator

Divide your weekly dose into multiple injections

Track Empagliflozin with Doseline

Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.

Join the waitlist

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.